Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2000 Feb 1;97(3):1212-7.
doi: 10.1073/pnas.97.3.1212.

A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy

Affiliations
Free PMC article
Case Reports

A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy

C G Bönnemann et al. Proc Natl Acad Sci U S A. .
Free PMC article

Abstract

Multiple epiphyseal dysplasia (MED) is a degenerative cartilage condition shown in some cases to be caused by mutations in genes encoding cartilage oligomeric matrix protein or type IX collagen. We studied a family with autosomal dominant MED affecting predominantly the knee joints and a mild proximal myopathy. Genetic linkage to the COL9A3 locus on chromosome 20q13.3 was established with a peak log(10) odds ratio for linkage score of 3.87 for markers D20S93 and D20S164. Reverse transcription-PCR performed on the muscle biopsy revealed aberrant mRNA lacking exon 3, which predicted a protein lacking 12 amino acids from the COL3 domain of alpha3(IX) collagen. Direct sequencing of genomic DNA confirmed the presence of a splice acceptor mutation in intron 2 of the COL9A3 gene (intervening sequence 2, G-A, -1) only in affected family members. By electron microscopy, chondrocytes from epiphyseal cartilage exhibited dilated rough endoplasmic reticulum containing linear lamellae of alternating electron-dense and electron-lucent material, reflecting abnormal processing of mutant protein. Type IX collagen chains appeared normal in size and quantity but showed defective cross-linking by Western blotting. The novel phenotype of MED and mild myopathy is likely caused by a dominant-negative effect of the exon 3-skipping mutation in the COL9A3 gene. Patients with MED and a waddling gait but minimal radiographic hip involvement should be evaluated for a primary myopathy and a mutation in type IX collagen.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigree of MED with mild myopathy genotyped at markers from chromosome 20q13.3. The disease haplotype is boxed. All affected family members share a common allele of markers D20S173, D20S93, and D20S164. D20S93* lies within an intron of the COL9A3 gene (34). Circles, female; squares, male; shaded symbols, affected; open symbols, unaffected.
Figure 2
Figure 2
(a--d) Radiographs from the proband (individual IV-5) at 10 yr of age. (a) Anteroposterior view of both knees. Epiphyses are abnormally shaped especially at subchondral bone regions. (b) Abnormal ankle radiograph with irregular shaping of distal tibial epiphysis and a rounded talar surface. (c) Anteroposterior radiograph centered at the wrist shows irregular carpals and a mildly shortened distal ulna. (d) Normal hip and pelvic radiograph. Knee radiographs showing progressive degenerative osteoarthritis in (e) individual III-9 at 38 yr and her mother II-3 at 52 yr (f) and 63 yr (g).
Figure 3
Figure 3
Histogram of quadriceps muscle biopsy from the proband showing mild variability in fiber diameter compared with an age-matched control.
Figure 4
Figure 4
Electron micrographs of epiphyseal chondrocytes with dilated RER containing (a) linear lamellar material in longitudinal section (×8,000) and (b) hexagonal arrays of punctate material in cross-section (×12,970). Fat inclusions are seen in both the cytoplasm and RER.
Figure 5
Figure 5
(a) Reverse transcription–PCR from skeletal muscle cDNA using primers flanking the mutation. Lane M, molecular size markers in bp; lane 1, patient sample showing a normal upper band and an abnormal lower band lacking the 36-bp exon 3; lane 2, normal control containing a single upper band; lane 3, negative control without DNA. (b) Chromatogram of genomic DNA sequence from the proband. The G-to-A mutation is present in a heterozygous state at position −1 with respect to the exon (formula image). (c) Schematic of the splice defect relative to the domain structure of COL9A3. COL1–3, collagenous domains 1–3; and NC1–4, noncollagenous domains 1–4.
Figure 6
Figure 6
Collagen IX protein analysis. (a) Western blot analysis of denaturant-extracted intact collagen type IX chains showing no apparent quantitative difference between control (CNTL) and patient (MED) samples. (b) Western blot analysis of CNBr-extracted, cross-linked collagen IX fragments showing a clear deficiency in cross-linked α3CB6 fragments in patient (MED) compared with control (CNTL) samples.

References

    1. Fairbank T. Br J Surg. 1947;34:225–232. - PubMed
    1. Rimoin D L, Rasmussen I M, Briggs M D, Roughly P J, Gruber H E, Warman M L, Olsen B R, Hsia Y E, Yuen J, Reinker K, et al. Hum Genet. 1994;93:236–242. - PubMed
    1. Ribbing S. Acta Radiol Suppl. 1937;34:1–107.
    1. International Working Group on Constitutional Disorders of Bone. Am J Med Genet. 1998;79:376–382. - PubMed
    1. Briggs M D, Hoffman S M, King L M, Olsen A S, Mohrenweiser H, Leroy J G, Mortier G R, Rimoin D L, Lachman R S, Gaines E S, et al. Nat Genet. 1995;10:330–336. - PubMed

Publication types